SOUTH SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / December 23, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company focused on developing CID-103, a potential ...
MindWalk (NASDAQ: HYFT), a BioNative AI biotherapeutic research and technology company combining in silico and wet lab ...
Antibody-based therapies are used to treat numerous diseases, from cancer to rheumatic disorders and multiple sclerosis.
Researchers are striving to understand the impact a phenomenon known as original antigenic sin has on immunity to the virus.
Neoantigen vaccines are at the forefront of cancer research, driving personalized immunotherapy and improving outcomes ...
Adults with shrimp allergy report reduced quality of life and a desire for therapies that would allow them to safely eat a full serving of shrimp.
REDWOOD CITY, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced the publication in Nature ...
DECLARATION is a Phase 3, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of VYD2311 in the prevention of COVID ...
Data from a new mouse model may help advance therapeutic development in celiac disease, including improved TG2 inhibitors and ...
News Medical on MSN
Genome Differences May Explain Why Some Antibody Drugs Fail
Common genetic variants can prevent antibody therapies from binding their targets, reducing treatment effectiveness. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback